Overview

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
A Phase I, Multi-Centre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940, Including an Interaction Study, After Administration of Oral Multiple Ascending Doses in Adult Subjects with Chronic Low Back Pain
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Midazolam